Who owns CALIDI BIOTHERAPEUTICS INC?
- Ticker: CLDI
- CUSIP Number: 320703408
Tip: Access positions for across all investors
Analyze quarterly positions in Calidi Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Calidi Biotherapeutics stock
Who bought or sold CALIDI BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Armistice Capital | 879k | $210k | 100% | Mar 2026 |
|
| Warberg Asset Management | 250k | $60k | 100% | Mar 2026 |
|
| HighTower Advisors | 84k | $20k | 0% | Mar 2026 |
|
| Geode Capital Management | 63k | $15k | 50% | Mar 2026 |
|
| Rs Crum | 40k | $9.6k | 99% | Mar 2026 |
|
| SRS Capital Advisors | 37k | $8.9k | 100% | Mar 2026 |
|
| Jane Street | 35k | $8.3k | 203% | Mar 2026 |
|
| Vanguard Group | 35k | $41k | 0% | Dec 2025 |
|
| Vanguard Capital Management | 26k | $6.1k | 100% | Mar 2026 |
|
| FMR | 22k | $26k | 17510% | Dec 2025 |
|
| Virtu Financial | 21k | $25k | 100% | Dec 2025 |
|
| Belpointe Asset Management | 20k | $4.8k | 0% | Mar 2026 |
|
| Northern Trust | 18k | $21k | 100% | Dec 2025 |
|
| Hrt Financial | 10k | $2.0k | 100% | Mar 2026 |
|
| Farther Finance Advisors | 10k | $2.4k | 0% | Mar 2026 |
|
| Morgan Stanley | 9.5k | $2.3k | 545% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 9.2k | $2.2k | 100% | Mar 2026 |
|
| Tower Research Capital | 2.8k | $3.2k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 2.1k | $2.5k | 1333% | Dec 2025 |
|
| Apollo Management Holdings | 1.0k | $1.2k | 0% | Dec 2025 |
|
| Highbridge Capital Management | 1.0k | $1.2k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 1.0k | $247.996000 | 11478% | Mar 2026 |
|
| Finepoint Capital | 1.0k | $249.038000 | 0% | Mar 2026 |
|
| SBI Securities | 115.00 | $27.002000 | 150% | Mar 2026 |
|
| Tradewinds Capital Management | 101.00 | $24.997500 | 0% | Mar 2026 |
|
| Reyes Financial Architecture | 100.00 | $24.000000 | 0% | Mar 2026 |
|
| CVA Family Office | 42.00 | $10.000200 | 0% | Mar 2026 |
|
| Citigroup | 14.00 | $3.000200 | 100% | Mar 2026 |
|
| Evermay Wealth Management | 1.00 | $1.000000 | 0% | Mar 2026 |
|
Who sold out of Calidi Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| DRW Holdings | Dec 2025 | 148k | $173k |
| UBS Group | Dec 2025 | 7.5k | $8.8k |
| Royal Bank of Canada | Sep 2025 | 417.00 | $1.0k |
| Barrett & Company | Dec 2025 | 292.00 | $341.990400 |
| Northwestern Mutual Wealth Management Company | Dec 2025 | 28.00 | $33.000800 |